Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): A four-year follow-up

Journal of the American College of Cardiology

Volumn 34, Issue 5, 1999, Pages 1498-1506

  Betriu, Amadeo ^a   Masotti, Monica ^a   Serra, Antoni ^a   Alonso, Joaquin ^b   Fernández Avilés, Francisco ^b   Gimeno, Federico ^b   Colman, Thierry ^c   Zueco, Javier ^c   Delcan, Juan L ^d   García, Eulogio ^d   Calabuig, José ^e  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD VESSEL DIAMETER; CORONARY ARTERY DISEASE; CORONARY STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; SPAIN; SURGICAL MORTALITY; TREATMENT OUTCOME;

EID: 0033230602     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00366-6     Document Type: Article

References (35)

1. Holmes D.R., Vliestra R.E., Smith H.C., et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA) a report from the PTCA registry of the National Heart, Lung, and Blood Institute . Am J Cardiol. 53:1984;77C-81C.
2. Mata L.A., Bosch X., David P.R., Rapold H.J., Corcos T., Bourassa M.G. Clinical and angiographic assessment 6 months after double vessel percutaneous coronary angioplasty. J Am Coll Cardiol. 6:1985;1339-1344.
3. Califf R.M., Fortin D.F., Frid D.J., et al. Restenosis after coronary angioplasty an overview . J Am Coll Cardiol. 17:1991;2-13B.
4. Beatt K.J., Serruys P.W., Hugenholtz P.G. Restenosis after coronary angioplasty new standards for clinical studies . J Am Coll Cardiol. 66:1990;926-931.
5. Rensing B.J., Hermans W.R.M., Deckers J.W., de Feyter P.J., Tijssen J.G.P., Serruys P.W. Lumen narrowing after percutaneous transluminal coronary balloon angioplasty follows a near gaussian distribution a quantitative angiographic study in 1,445 successfully dilated lesions . J Am Coll Cardiol. 19:1992;939-945.
6. Ernst S.M.P.G., van der Feltz T.A., Bal E.T., et al. Long term angiographic follow-up, cardiac events, and survival in patients undergoing percutaneous transluminal coronary angioplasty. Br Heart J. 57:1987;220-225.
7. Serruys P.W., Luijten H.E., Beatt K.J., et al. Incidence of restenosis after successful coronary angioplasty a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months . Circulation. 77:1988;361-371.
8. Nobuyoshi M., Kimura T., Nosaka H., et al. Restenosis after successful percutaneous transluminal coronary angioplasty serial angiographic follow-up of 229 patients . J Am Coll Cardiol. 12:1988;616-623.
9. Hermans W.R.M., Rensing B.J., Kelder J.C., de Feyter P.J., Serruys P.W. Postangioplasty restenosis rate between segments of the major coronary arteries. Am J Cardiol. 69:1992;194-200.
10. REDUCE Trial Group , Karsch K.R., Preisack M.B., Baildon R., et al. Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE) . J Am Coll Cardiol. 28:1996;1437-1443.
11. Yokoi H., Daida H., Kuwabara Y., et al. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty the probucol angioplasty restenosis trial . J Am Coll Cardiol. 30:1997;855-862.
12. Bauters C., Meurice T., Hamon M., McFadden E., Lablanche J.M., Bertrand M.E. Mechanisms and prevention of restenosis from experimental models to clinical practice . Cardiovasc Res. 31:1996;835-846.
13. Lefkovits J., Topol E.J. Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention. Prog Cardiovasc Dis. 40:1997;141-158.
14. Watanabe K., Sekiya M., Ikera S., Miyagawa M., Hashida K. Preventive effect of probucol on restenosis after percutaneous transluminal coronary angioplasty. Am Heart J. 132:1996;23-29.
15. Lablanche J.M., McFadden E.P., Meneveau N., et al. Effect of Nadroparin, a low-molecular weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty the FACT Study . Circulation. 96:1997;3369-3402.
16. Serruys P.W., de Jaegere P., Kiemeneij F., et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 331:1994;489-495.
17. Fischman D.L., Leon M.B., Baim D.S., et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 331:1994;496-501.
18. Bittl J.A., Sanborn T.A. Exicimer laser-facilitated coronary angioplasty relative risk analysis of acute and follow-up results in 200 patients . Circulation. 86:1992;71-80.
19. Topol E.J., Leya F., Pinkerton C.A., et al. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med. 329:1993;221-227.
20. Adelman A.G., Cohen E.A., Kimball B.P., et al. A Comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery. N Engl J Med. 329:1993;228-233.
21. BOAT Investigators , Baim D.S., Cutlip D.E., Sharma S.K., et al. Final Results of the balloon vs optimal atherectomy trial (BOAT). Circulation. 97:1998;322-331.
22. Simontom C.A., Leon M.B., Baim D.S., et al. Optimal directional coronary atherectomy. Final results of the optimal atherectomy restenosis study (OARS). Circulation. 97:1998;332-339.
23. Mancini G.J.B., Simon S.B., McGillem M.J., LeFree M.T., Friedman H.Z., Vogel R.A. Automated quantitative coronary arteriography morphologic and physiologic validation in vivo of a rapid digital angiographic method . Circulation. 75:1987;452-460.
24. Blackburn H., Keys A., Simonson E., Rantaharju P., Punsar S. The electrocardiogram in population studies. A classification system. Circulation. 21:1960;1160-1175.
25. Ryan T.J., Faxon D.P., Gunnar R.M., et al. Guidelines for percutaneous transluminal coronary angioplasty a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty) . J Am Coll Cardiol. 12:1988;529-545.
26. Betriu A., Serra A., Masotti M., et al. Are national randomized trials a necessary evil? J Intervent Cardiol. 7:1994;345-353.
27. Shatz R.A., Goldberg S., Leon M., et al. Clinical experience with the Palmaz-Schatz coronary stent. J Am Coll Cardiol. 17:1991;155-159B.
28. Serruys P.W., Strauss B.H., Beat K.J., et al. Angiographic follow-up after placement of a self-expanding coronary artery stent. N Engl J Med. 324:1991;13-17.
29. Kimura T., Nosaka H., Yokoi H., Iwabuchi M., Nobuyoshi M. Serial angiographic follow-up after Palmaz-Schatz stent implantation comparison with conventional balloon angioplasty . J Am Coll Cardiol. 21:1993;1557-1563.
30. Haude M., Erbel R., Straub U., et al. Short- and long-term results after intracoronary stenting in human coronary arteries monocenter experience with the balloon-expandable Palmaz-Schatz tent . Br Heart J. 66:1991;337-345.
31. Díaz L., Fajadet J., Cassagneau B., Robert G., Marco J. The short-term results and angiographic predictors of subacute thrombosis in the coronary implantation of the Palmaz-Schatz endoprosthesis. Rev Esp Cardiol. 47:1994;747-753.
32. Thornton M.A., Grüntzig A.R., Hollman J., et al. Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty a randomized study . Circulation. 69:1984;721-727.
33. Urban P., Buller N., Kox K., et al. Lack of effect of warfarin on the restenosis rate or on clinical outcome after balloon coronary angioplasty. Br Heart J. 60:1988;485-488.
34. Topol E.J. Caveats about elective coronary stenting. N Engl J Med. 331:1994;539-541.
35. Iñiguez A. Intracoronary prosthesis (stent) an approach to the analysis of cost-effectiveness . Rev Esp Cardiol. 50:(Suppl 2):1997;83-94.